Searched for
PRE EXPOSURE PROPHYLAXIS
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- HIV-prevention drug to cost $40 a year from 2027The two organizations have signed separate agreements with Indian pharmaceutical companies to produce cheaper generics of lenacapavir - a t...
- US funding cuts could reverse decades of gains in AIDS fight: UNThe United Nations warns that the halt to US foreign aid, initiated by President Trump in February 2025, poses a significant threat to glob...
- Lenacapavir HIV shot approved in US may enter Canada by 2026; just two injections needed a yearA twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by mid-2026. Develope...
- US approves Gilead's twice-yearly injection to prevent HIVThe US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the company hail...
- Activists sound alarm bells as Gilead seeks rights over HIV drugLenacapavir, a very expensive drug, is not available in India and many other countries. If the Indian Patent Office clears Gilead's patent ...
- HIV breakthrough: Drug trial shows injection twice a year is 100% effective against infectionThe trial tested whether the six-month injection of lenacapavir would provide better protection against HIV infection than two other drugs,...
- European Commission authorises GSK's HIV prevention drugCabotegravir is recommended in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually-acqu...
- Aurobindo, Cipla, Viatris in licensing pact with MPP to make ViiV's HIV preventive therapyThrough the MPP-ViiV Healthcare agreement, the three generic manufacturers will be able to develop, manufacture, and supply generic version...
- The changing tides of time, how life with HIV is no longer a death sentenceLiving with HIV is as simple as taking a single pill a day to keep the virus undetectable in your blood.
- Molnupiravir authorisation comes with a condition - further trials in the next three monthsAccording to one of the conditions, as post marketing surveillance the companies will have to submit periodic safety update reports to the ...
- USFDA study shows Evusheld retains neutralising activity against Omicron: AstraZenecaEvusheld is the first long-acting antibody to receive emergency use authorisation in the US for pre-exposure prophylaxis of COVID-19, in ad...
- AstraZeneca adds 2.5% after initiating talks on Covid prevention drug with Indian authoritiesEvusheld, a Covid-19 prevention drug for individuals with weakened immune systems, has received emergency use authorisation in the US.
- AZ to seek India nod for antibody cocktailEvusheld is a combination of tixagevimab and cilgavimab. The drug received EUA in the US on Thursday for pre-exposure prophylaxis or preven...
- AstraZeneca in touch with Indian authorities for approval to COVID drugThe company also said studies are underway to provide information on the impact of the new Omicron variant on Evusheld, which is being deve...
- Lupin launches generic HIV-1 drug in USThe drug maker's product is the generic version of Gilead Sciences, Inc's Truvada tablets and indicated in combination with other antiretro...
- Lupin gets USFDA nod to market generic HIV drugThe company has received approval from the United States Food and Drug Administration (USFDA) to market its Emtricitabine and Tenofovir Dis...
- WHO ending hydroxycholorquine trial for COVIDWHO says a review of the interim results showed hydroxychloroquine and lopinavir/ritonavir "produce little or no reduction in the mortality...
- Zydus Cadila receives DCGI nod to market rabies drug in IndiaZydus said it currently also manufactures and markets the rabies vaccine — VaxiRab.
- Anti-AIDS medicine project likely to take off at SonagachiUnder the project PrEP, regular medicine would be given to an HIV-negative sex worker engaged in sex with an HIV-positive person.
Load More
